Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Integrated Sciences Inc (NQ: NVOS )

0.2600 -0.0147 (-5.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Novo Integrated Sciences Inc

< Previous 1 2 Next >
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Provides Update on Potential Share Repurchase Program
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 Coupon
From Novo Integrated Sciences, Inc.
Via Business Wire
Acenzia Selected to join Team Canada Trade Mission to India
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences and Farm 7 Group Announce Joint Venture for Kenya Cooperative Agricultural Project
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions
From Novo Integrated Sciences, Inc.
Via Business Wire
Embracing Technology and Innovation “Key” to Easing Healthcare Crisis
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public Offering
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of... 
Via PRUnderground
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
Bellevue, WA, United States - 04-26-2022 - 
Via PR Distribution
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
From Novo Integrated Sciences, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.